Acceleron Pharma Inc. EBITDA Margin 2013-2021 | XLRN
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Acceleron Pharma Inc. (XLRN) over the last 10 years. The current EBITDA margin for Acceleron Pharma Inc. as of September 30, 2021 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2021-09-30 | $0.11B | $-0.25B | -223.01% |
| 2021-06-30 | $0.10B | $-0.22B | -216.67% |
| 2021-03-31 | $0.11B | $-0.18B | -154.39% |
| 2020-12-31 | $0.09B | $-0.16B | -176.34% |
| 2020-09-30 | $0.11B | $-0.13B | -124.53% |
| 2020-06-30 | $0.09B | $-0.14B | -163.22% |
| 2020-03-31 | $0.08B | $-0.14B | -192.00% |
| 2019-12-31 | $0.07B | $-0.13B | -179.73% |
| 2019-09-30 | $0.04B | $-0.14B | -369.23% |
| 2019-06-30 | $0.04B | $-0.13B | -328.95% |
| 2019-03-31 | $0.01B | $-0.13B | -957.14% |
| 2018-12-31 | $0.01B | $-0.12B | -864.29% |
| 2018-09-30 | $0.01B | $-0.11B | -807.14% |
| 2018-06-30 | $0.01B | $-0.11B | -778.57% |
| 2018-03-31 | $0.01B | $-0.11B | -838.46% |
| 2017-12-31 | $0.01B | $-0.11B | -764.29% |
| 2017-09-30 | $0.01B | $-0.10B | -769.23% |
| 2017-06-30 | $0.01B | $-0.10B | -730.77% |
| 2017-03-31 | $0.01B | $-0.09B | -661.54% |
| 2016-12-31 | $0.03B | $-0.07B | -240.74% |
| 2016-09-30 | $0.03B | $-0.06B | -221.43% |
| 2016-06-30 | $0.03B | $-0.06B | -193.10% |
| 2016-03-31 | $0.03B | $-0.05B | -153.13% |
| 2015-12-31 | $0.02B | $-0.06B | -338.89% |
| 2015-09-30 | $0.02B | $-0.06B | -316.67% |
| 2015-06-30 | $0.02B | $-0.05B | -300.00% |
| 2015-03-31 | $0.02B | $-0.06B | -362.50% |
| 2014-12-31 | $0.02B | $-0.05B | -360.00% |
| 2014-09-30 | $0.02B | $-0.04B | -186.96% |
| 2014-06-30 | $0.02B | $-0.04B | -169.57% |
| 2014-03-31 | $0.05B | $-0.01B | -15.56% |
| 2013-12-31 | $0.06B | $0.01B | 14.04% |
| 2013-09-30 | $0.05B | $0.00B | 8.16% |
